An announcement from Neurocrine ( ($NBIX) ) is now available. On January 24, 2025, Neurocrine Biosciences announced an amendment to its Exclusive ...
BioMed Realty, a Blackstone portfolio company and the largest private operator of life science real estate, alongside Suffolk ...
The Public Theater and Ma-Yi Theater Company will soon present the New York premiere of SUMO, a thrilling new play written by ...
Investing.com -- Keros Therapeutics, Inc. (NASDAQ: KROS) shares rose 6% following the announcement of the effectiveness of its global license agreement with pharmaceutical giant Takeda. The deal, ...
When it comes to the bumper $62bn takeover of UK drugs group Shire by its larger Japanese rival Takeda Pharmaceutical (whose shares have returned 32pc since the acquisition completed at the start of ...
SOLANA BEACH, CALIFORNIA / ACCESS Newswire / January 27, 2025 / ClearPoint Neuro, Inc. (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the ...
(Photo: Business Wire) Takeda has leased the property’s approximately ... 30,000-square-foot performing arts center with a 400-seat performance space, flexible multipurpose rooms for workshops ...
Takeda has leased the property’s approximately ... The building’s 30,000-square-foot performing arts center with a 400-seat performance space, flexible multipurpose rooms for workshops and ...
DelveInsight's“Lennox–Gastaut syndrome Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Lennox–Gastaut syndrome, historical and forecasted ...
Tempus AI claims to have a one-stop-shop, with a flywheel platform that becomes better with each new client. See why I rate ...
Harmony Biosciences' Wakix shows promise for significant revenue growth. Find out why HRMY stock’s profitability and pipeline ...
Takeda could acquire next-generation immunotherapies ... paper from Altmetric – ‘The changing landscape of journal performance measurement’ – learn how publication planners and medical ...